Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Total Non-Current Liabilities (2020 - 2025)

RxSight's Total Non-Current Liabilities history spans 6 years, with the latest figure at $32.9 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 7.56% year-over-year to $32.9 million; the TTM value through Dec 2025 reached $32.9 million, down 7.56%, while the annual FY2025 figure was $32.9 million, 7.56% down from the prior year.
  • Total Non-Current Liabilities reached $32.9 million in Q4 2025 per RXST's latest filing, up from $32.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $60.3 million in Q4 2022 to a low of $19.2 million in Q1 2024.
  • Average Total Non-Current Liabilities over 5 years is $36.6 million, with a median of $33.2 million recorded in 2024.
  • Peak YoY movement for Total Non-Current Liabilities: crashed 63.3% in 2023, then soared 75.34% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $54.5 million in 2021, then rose by 10.62% to $60.3 million in 2022, then plummeted by 63.3% to $22.1 million in 2023, then surged by 61.1% to $35.6 million in 2024, then fell by 7.56% to $32.9 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Total Non-Current Liabilities are $32.9 million (Q4 2025), $32.6 million (Q3 2025), and $31.0 million (Q2 2025).